-
1
-
-
0034838788
-
Plasma leptin concentrations are associated with bone mineral density and the presence of vertebral fractures in post menopausal women
-
Yamauchi M, Sugimoto T, Yamaguchi T et al. Plasma leptin concentrations are associated with bone mineral density and the presence of vertebral fractures in post menopausal women. Clin Endocrinol (Oxford) 2001;55:341-347.
-
(2001)
Clin Endocrinol (Oxford)
, vol.55
, pp. 341-347
-
-
Yamauchi, M.1
Sugimoto, T.2
Yamaguchi, T.3
-
2
-
-
0036252175
-
Plasma lipids and osteoporosis in post menopausal women
-
Yamaguchi T, Sugimoto T, Yano S et al. Plasma lipids and osteoporosis in post menopausal women. Endocr J 2002;49:211-217.
-
(2002)
Endocr J
, vol.49
, pp. 211-217
-
-
Yamaguchi, T.1
Sugimoto, T.2
Yano, S.3
-
3
-
-
0033521078
-
Stimulation of bone formation in vitro and in rodents by statins
-
Mundy G, Garrett R, Harris S et al. Stimulation of bone formation in vitro and in rodents by statins. Science 1999;286:1946-1949.
-
(1999)
Science
, vol.286
, pp. 1946-1949
-
-
Mundy, G.1
Garrett, R.2
Harris, S.3
-
4
-
-
0034725357
-
HMG-CoA reductase inbibitors and the risk of hip fractures in elderly patients
-
Wang PS, Solomon DH, Mogun H et al. HMG-CoA reductase inbibitors and the risk of hip fractures in elderly patients. JAMA 2000;283:3211-3216.
-
(2000)
JAMA
, vol.283
, pp. 3211-3216
-
-
Wang, P.S.1
Solomon, D.H.2
Mogun, H.3
-
5
-
-
18544410718
-
Inhibitors of hydroxymethylglutaryl-coenzyme A reductase and risk of fracture among older women
-
Chan KA, Andrade SE, Boles M et al. Inhibitors of hydroxymethylglutaryl-coenzyme A reductase and risk of fracture among older women. Lancet 2000;355:2185-2188.
-
(2000)
Lancet
, vol.355
, pp. 2185-2188
-
-
Chan, K.A.1
Andrade, S.E.2
Boles, M.3
-
6
-
-
0034957690
-
The effect of fluvastatin on parameters of bone remodeling
-
Bjarnason NH, Riis BJ, Christiansen C. The effect of fluvastatin on parameters of bone remodeling. Osteoporos Int 2001;12:380-384.
-
(2001)
Osteoporos Int
, vol.12
, pp. 380-384
-
-
Bjarnason, N.H.1
Riis, B.J.2
Christiansen, C.3
-
7
-
-
0034454445
-
HMG-CoA reductase inhibitors increase BMD in type 2 diabetes mellitus patients
-
Chung YS, Lee MD, Lee SK et al. HMG-CoA reductase inhibitors increase BMD in type 2 diabetes mellitus patients. J Clin Endocrinol Metab 2000;85:1137-1142.
-
(2000)
J Clin Endocrinol Metab
, vol.85
, pp. 1137-1142
-
-
Chung, Y.S.1
Lee, M.D.2
Lee, S.K.3
-
8
-
-
0035901052
-
Effect of pravastatin on frequency of fracture in the Lipid study: Secondary analysis of a randomized controlled trial
-
Reid IR, Hague W, Emberson J et al. Effect of pravastatin on frequency of fracture in the Lipid study: Secondary analysis of a randomized controlled trial. Lancet 2001;357:509-512.
-
(2001)
Lancet
, vol.357
, pp. 509-512
-
-
Reid, I.R.1
Hague, W.2
Emberson, J.3
-
9
-
-
0033958778
-
Alendronate is a specific nana molar inhibitor of farnesyl diphosphate synthase
-
Bergstrom JD, Bostedor RG, Masarachia PJ et al. Alendronate is a specific nana molar inhibitor of farnesyl diphosphate synthase. Arch Biochem Biophys 2000;373:231-241.
-
(2000)
Arch Biochem Biophys
, vol.373
, pp. 231-241
-
-
Bergstrom, J.D.1
Bostedor, R.G.2
Masarachia, P.J.3
-
10
-
-
0036190491
-
Statin use, bone mineral density, and fracture risk: Geelong osteoporosis study
-
Pasco JA, Kotowicz MA, Henry MJ et al. Statin use, bone mineral density, and fracture risk: Geelong osteoporosis study. Arch Intern Med 2002;162:537-540.
-
(2002)
Arch Intern Med
, vol.162
, pp. 537-540
-
-
Pasco, J.A.1
Kotowicz, M.A.2
Henry, M.J.3
|